<DOC>
	<DOCNO>NCT00642434</DOCNO>
	<brief_summary>The purpose study determine difference , ( benefit ) carvedilol metoprolol treatment HTN patient type 2 diabetes . Specifically look difference blood pressure blood sugar control , endothelial function , inflammation , oxidative stress coagulation . Subjects randomize one two beta-blockers follow 5 month . Each subject undergo 4 inpatient study oral glucose tolerance test do , Inflammatory oxidative stress marker measure . Endothelial function measure use brachial artery ultrasound laser skin Doppler</brief_summary>
	<brief_title>Comparison Blood Pressure Medications Metabolism</brief_title>
	<detailed_description />
	<mesh_term>Carvedilol</mesh_term>
	<mesh_term>Metoprolol</mesh_term>
	<criteria>enrol enrol</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>diabetes blood pressure oxidative stress</keyword>
</DOC>